4.7 Review

Nuclear factor-κB and liver carcinogenesis

期刊

CANCER LETTERS
卷 229, 期 2, 页码 157-169

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2005.07.008

关键词

nuclear factor-kappa B; liver carcinogenesis; hepatocellular carcinomas; apoptosis; TGF-alpha; TGF-beta1; HGF-1; HBV; HCV; AFP

类别

资金

  1. NCI NIH HHS [CA78616, CA78616-S] Funding Source: Medline

向作者/读者索取更多资源

Hepatocellular carcinoma (HCC) is the third deadliest and fifth most common human cancer worldwide. Hepatitis C virus (HCV) and hepatitis B virus (HBV) infections along with alcohol and aflatoxin B1 intake are widely recognized etiological agents in HCCs. It is anticipated that HCCs will constitute a major health problem in the next two decades because of the rising incidence of HCV infections in the US. The poor survival rate achieved by current surgical procedures and chemotherapy treatment has prompted the scientific community to gain a better understanding of the molecular events involved in hepatocarcinogenesis in order to define new targets for more effective treatment. Recent findings from several laboratories have implicated constitutive activation of the transcription factor NF-kappa B as one of the early key events involved in neoplastic progression of the liver. Data is summarized here from recently published studies illustrating a crucial role of NF-kappa B in bridging the action of growth factors and inflammation to hepatic oncogenesis. Although additional work is needed to fully understand the precise role of NF-kappa B in the regulation of the various transitions of HCC development, these new findings raise the intriguing possibility that pharmacologic inhibition of NF-kappa B in the liver could selectively eradicate malignant liver cells without affecting normal liver homeostasis. (c) 2005 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据